167 related articles for article (PubMed ID: 23389833)
1. High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations.
Chandarana H; Amarosa A; Huang WC; Kang SK; Taneja S; Melamed J; Kim S
J Magn Reson Imaging; 2013 Oct; 38(4):802-8. PubMed ID: 23389833
[TBL] [Abstract][Full Text] [Related]
2. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
4. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.
Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation.
Chandarana H; Kang SK; Wong S; Rusinek H; Zhang JL; Arizono S; Huang WC; Melamed J; Babb JS; Suan EF; Lee VS; Sigmund EE
Invest Radiol; 2012 Dec; 47(12):688-96. PubMed ID: 22996315
[TBL] [Abstract][Full Text] [Related]
7. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in the evaluation of small (< or =3.0 cm) renal masses.
Rofsky NM; Bosniak MA
Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):67-81. PubMed ID: 8995125
[TBL] [Abstract][Full Text] [Related]
9. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
Kim S; Quon H; Loevner LA; Rosen MA; Dougherty L; Kilger AM; Glickson JD; Poptani H
J Magn Reson Imaging; 2007 Dec; 26(6):1607-17. PubMed ID: 17968962
[TBL] [Abstract][Full Text] [Related]
10. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
12. Oncocytic renal neoplasms: diagnostic considerations.
Abrahams NA; Tamboli P
Clin Lab Med; 2005 Jun; 25(2):317-39, vi. PubMed ID: 15848739
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
14. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
16. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.
Kim JH; Bae JH; Lee KW; Kim ME; Park SJ; Park JY
Urology; 2012 Oct; 80(4):872-6. PubMed ID: 22854134
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
[TBL] [Abstract][Full Text] [Related]
19. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation.
Gaens ME; Backes WH; Rozel S; Lipperts M; Sanders SN; Jaspers K; Cleutjens JP; Sluimer JC; Heeneman S; Daemen MJ; Welten RJ; Daemen JW; Wildberger JE; Kwee RM; Kooi ME
Radiology; 2013 Jan; 266(1):271-9. PubMed ID: 23151823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
